image
Healthcare - Biotechnology - NASDAQ - US
$ 3.165
-6.61 %
$ 122 M
Market Cap
-2.18
P/E
BALANCE SHEET
181 M ASSETS
129.82%
14.3 M LIABILITIES
34.68%
167 M EQUITY
144.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Protara Therapeutics, Inc.
image
Current Assets 172 M
Cash & Short-Term Investments 170 M
Receivables 0
Other Current Assets 1.86 M
Non-Current Assets 9.3 M
Long-Term Investments 0
PP&E 5.28 M
Other Non-Current Assets 4.02 M
93.85 %2.91 %Total Assets$181.5m
Current Liabilities 11 M
Accounts Payable 4.43 M
Short-Term Debt 1.12 M
Other Current Liabilities 5.41 M
Non-Current Liabilities 3.36 M
Long-Term Debt 3.36 M
Other Non-Current Liabilities 0
30.93 %7.85 %37.77 %23.46 %Total Liabilities$14.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 162.8 39.6 24.1 35.7 168.6 6.2 19.4 21.2 36.4 40.0 68.8 2.8 2.4
Short Term Investments 7.5 26.0 60.2 55.5 0 0 2.5 21.0 4.9 25.2 14.8 2.4 5.1
Receivables 0 0.2 0.5 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 1.2 1.2 0 0 0 0 0 0 0 0 0
Other Current Assets 6.0 4.9 8.5 7.7 3.9 0.5 0.2
Total Current Assets 273.3 253.1 354.9 240.2 315.3 37.5 8.2
PP&E 110.7 119.3 107.7 24.5 17.9 10.2 1.3
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 110.4 0 2.7 2.1 0.4 0.3 89.8 K
Other Long Term Assets 6.8 6.5 7.7 7.1 4.1 0.5 0
Other Assets 0 0 0 0 0 0 0
Total Assets 501.2 378.9 472.9 273.9 337.6 48.4 9.6
LIABILITIES
Accounts Payable 0.6 3.7 1.8 1.1 1.2 1.9 0.4
Short Term Debt 12.1 6.1 8.5 5.0 2.8 1.5 0
Other Current Liabilities 4.3 13.6 11.8 6.9 4.9 4.8 1.7
Total Current Liabilities 18.9 23.3 17.8 10.5 7.5 8.2 2.1
Long Term Debt 74.2 82.3 78.7 10.0 7.5 5.8 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 87 K 0 0 18 K 82 K 59.9 12.9
Total Liabilities 93.2 105.6 100.7 22.9 16.4 73.9 15.0
EQUITY
Common Stock 7 K 5 K 5 K 3 K 3 K 160 123
Retained Earnings (544.2) (435.4) (317.9) (204.1) (118.0) (26.7) (5.6)
Other Accumulative Comprehensive Income/Loss 0.7 8 K (0.7) (0.1) 3 K 2.14 K (0.2)
Total Equity 408.0 273.3 372.2 251.0 321.2 (25.5) (5.4)
Total Liabilities and Equity 501.2 378.9 472.9 273.9 337.6 48.4 9.6
SHARES OUTSTANDING
Common Shares Outstanding 67.9 49.0 43.6 32.9 31.8 9.0 5 027.0